Improving standards in flexible bronchoscopy for lung cancer.

Area of Science:

• Pulmonology
• Oncology
• Medical Quality Improvement

Background:

• Flexible bronchoscopy is a key diagnostic tool for suspected lung malignancy.
• Optimizing its detection rate is crucial for timely cancer diagnosis and treatment.
• Quality improvement initiatives may enhance diagnostic performance.

Purpose of the Study:

• To evaluate if simple quality improvement measures can increase the detection rate of flexible bronchoscopy for lung cancer.
• To assess the diagnostic yield of different biopsy modalities.
• To identify factors influencing the diagnostic success of bronchoscopy.

Main Methods:

• Prospective recording of bronchoscopy-associated clinical parameters from 2001 to 2007 in 704 patients with suspected lung malignancy.
• Analysis of detection rates, diagnostic yield of biopsy techniques, and impact of service improvements.
• Logistic regression used to identify independent predictors of a positive diagnosis.

Main Results:

• The overall detection rate for malignancy via flexible bronchoscopy was 83.6%.
• Detection rates significantly increased from 67.3% in 2001 to 89.7% in 2007 (p<0.001).
• Improvements were observed for both visible (75.0% to 94.5%) and non-visible tumors (41.7% to 81.2%).

Conclusions:

• A series of simple quality improvement measures led to a significant increase in the bronchoscopic detection rate for lung malignancy.
• Tumor visibility, study year, transbronchial needle aspiration, and pathologist identity were independent predictors of diagnosis.
• Continuous quality improvement is vital for enhancing diagnostic accuracy in flexible bronchoscopy for lung cancer.